On March 1, Vivus started its Save Now! program, which sets a discounted price of $75 for one 30-day supply of the company’s weight management medication Qsymia (7.5 mg...

The 2012 Diabetes Technology Meeting provides new insights into the artificial pancreas and the latest thinking on regulation from the FDA.

To mark the end of this month’s 72nd American Diabetes Association (ADA) Scientific Sessions in Philadelphia (see conference pearls in this issue), diaTribe editor in...

On November 28, CeQur announced that it had received CE Mark approval for its PaQ Insulin Delivery Device , allowing the product to be sold in Europe. The Swiss-based...

Kelly reveals how you can help change the truly unacceptable care people with diabetes are receiving in prison.

Weight expert Dr. David Cummings discusses why bariatric surgery goes far beyond weight loss for type 2 diabetes.

Michelle Obama at the Partnership for a Healthier America’s Summit.

Wireless, cell phone-enabled, and data-to-the-cloud glucose meters are a new trend in diabetes, evidenced by the recent launch of Sanofi’s iBGStar (see test drive in...

In late June, diaTribe sent our team to Chicago to attend the 67th Annual Scientific Sessions of the American Diabetes Association.

On February 8, Novo Nordisk received an FDA complete response letter (CRL) for Tresiba (insulin degludec) and Ryzodeg (insulin degludec/aspart). Tresiba is Novo Nordisk’...

Kerri Morrone Sparling reveals how the Internet has built an all new kind of diabetes community.

In time for the beginning of this school year, DC Public Schools (DCPS) took a major step toward providing access to essential care for all its students with diabetes...

Kelly reflects on some changes here at diaTribe and in the world of diabetes and obesity.

Kerri Sparling digs deep and tells us more about why social networking really does matter.

What really causes weight gain? A fascinating review in the New England Journal of Medicine details myths and facts about obesity.

On July 17, the FDA approved Vivus’ weight-loss medication Qsymia (formerly called Qnexa), just several weeks after the approval of Arena’s Belviq (see new now next in...

On November 29, NeuroMetrix announced that it had cleared the final hurdle holding up the introduction of the Sensus Pain Management System, designed for the treatment...

When it comes to patient advocacy, Kerri Morrone Sparling explains why even the little things can have a big impact.

On September 17, Vivus announced that its obesity medication Qsymia (formerly Qnexa) is now available on the US market – this happened at least several weeks earlier...

Dr. Diana Guthrie, winner of the AADE Living Legend Award, on controlled breathing and supplements for people with diabetes…